Class Action Targets St. Jude Medical

Law360, New York (April 11, 2006, 12:00 AM EDT) -- Medical device maker St. Jude Medical Inc. has been hit with a shareholder lawsuit alleging that the company misrepresented the sales of one of its products in order to boost earnings, causing the stock to trade at an inflated price.

The Minnesota-based company allegedly waited to record some third-quarter sales of its implantable cardioverter defibrillator system until the fourth quarter in order to boost revenues for that quarter.

Several analysts touted the company’s stock based on fourth-quarter results, and St. Jude projected earnings for the first...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.